Abstract
Phenytoin (PHT), phenobarbital (PHB), lamotrigine (LTG), and topiramate (TPM) are some of the most widely used antiepileptic drugs (AEDs). Monitoring of their concentrations in serum is important for the treatment of epilepsy. A reference measurement procedure (RMP) for certification of PHT, PHB, LTG, and TPM in serum has been developed and critically evaluated. Isotopically labeled compounds of PHT, PHB, LTG, and TPM are used as internal standards for the four AEDs. The four drugs and their respective labeled internal standards are simultaneously extracted from serum using solid-phase extraction prior to reversed-phase liquid chromatography–tandem mass spectrometry (LC-MS/MS). Chromatographic separation was performed using a C18 column. Electrospray ionization (ESI) in the positive ion mode for PHT and LTG, and in the negative ion mode for PHB and TPM were used. The recovery of AEDs added to serum (accuracy of the extraction method) was evaluated by recovery studies of measuring the four drugs in spiked samples with known drug levels. The recoveries of the added drugs ranged from 98.6% to 102.0%. The absolute recoveries (extraction efficiencies) of the four drugs with this method ranged from 97% to 100%. Excellent repeatability was obtained for the four drugs with between-set coefficients of variation (CVs) within 1%. The type B components estimates are conservatively large and are considerably larger than the type A component. Therefore, we use the usual metrological expansion factor of 2 to provide an approximate 95% coverage interval. The relative expanded uncertainties for the four AEDs ranged from 2.3% to 2.4%. This LC-MS/MS RMP for PHT, PHB, LTG, and TPM in serum demonstrating good accuracy and precision can be used to assess the accuracy of routine methods used in clinical laboratories.
Similar content being viewed by others
References
Tietz NW (1994) Tietz textbook of clinical chemistry, 2nd edn. Saunders, Philadelphia
Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN (2003) Ther Drug Monit 25:347–363
Tracy RP, Ebnet LE, Moyer TP (1979) Clin Chem 25:1868–1869
Foerster EH, Dempsey J, Garriott JC (1979) J Anal Toxicol 3:87–91
Gerson B, Anhalt JP (1980) High pressure liquid chromatography and therapeutic drug monitoring. ASCP, Chicago
Beck O, Ohman I, Nordgren HK (2006) Ther Drug Monit 28:603–607
Britzi M, Soback S, Isoherranen N, Levy RH, Perucca E, Doose DR, Maryanoff BE, Bialer M (2003) Ther Drug Monit 25:314–322
Zhang Y, Mehrotra N, Budha NR, Christensen ML, Meibohm B (2008) Clin Chim Acta 398:105–112
Subramanian M, Birnbaum AK, Remmel RP (2008) The Drug Monit 30:347–356
Speed DJ, Dickson SJ, Cairns ER, Kim ND (2000) J Anal Toxicol 24:685–690
Spell JC, Srinivasan K, Stewart JT, Bartleett MG (1998) Rapid Commun Mass Spectrom 12:890–894
Chen S, Carvey PM (1999) Rapid Commun Mass Spectrom 13:1980–1984
Matar KM (2010) Clin Chim Acta 411:729–734
Park J, Park Y, Lee M, Rhim S, Song J, Lee S, Kim J, Shaw LM, Kang J (2008) Biomed Chromatogr 22:822–829
Christensen J, Hojskov CS, Poulsen JH (2002) The Drug Monit 24:659–664
Greiner-Sosanko E, Lower DR, Virji MA, Krasowski MD (2007) Biomed Chromatogr 21:225–228
Vermeij TAC, Edelbroek PM (2007) J Chromatogr B 857:40–46
ISO 15193 (2003) http://www.iso.ch/iso/en/CatalogueListPage. CatalogueList
JCTLM (2005) http://www.bipm.org/en/committees/jc/jctlm/jctlm-db.
Tai SS, Xu B, Welch MJ, Phinney KW (2007) Anal Bioanal Chem 388:1087–1094
Tai SS, Xu B, Welch MJ (2006) Anal Chem 78:6628–6633
ISO (1993) Guide to the expression of uncertainty in measurement. International Organization for Standardization, Geneva, Switzerland
Ellison SLR, Barwick VJ, Farrant TJD (2009) Practical statistics for the analytical scientist: a bench guide, 2nd edn. RSC, Cambridge, UK
Bourgeois BF (1999) Drugs Today (BARC) 35:43–48
Tsiropoulos I, Kristensen O, Klitgaard NA (2000) The Drug Monit 22:517–521
Tai SS, Welch MJ (2004) Anal Chem 76:1008–1014
Ohnmacht CM, Chen S, Tong Z, Hage DS (2006) J Chromatogr B Analyt Technol Biomed Life Sci 836:83–91
Carrier DJ, Eckers C, Wolff JC (2008) J Pharm Biomed Anal 47:731–737
Matsuura H, Ohmori T, Nakamura M, Itoh Y, Hirano K (2008) Biomed Chromatogr 22:387–393
Acknowledgments
We thank Michele Schantz (NIST) for GC-FID analysis, Barbara Porter (NIST) for DSC analysis and Brian Lang (NIST) for Karl Fischer analysis for the purity assessment of the PHT, PHB, LTG, and TPM reference compounds.
Disclaimer
Certain commercial equipment, instruments, and materials are identified in this paper to adequately specify the experimental procedure. Such identification does not imply recommendation or endorsement by NIST nor does it imply that the equipment, instruments, or materials are necessarily the best available for the purpose.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 133 KB)
Rights and permissions
About this article
Cite this article
Tai, S.SC., Yeh, CY. & Phinney, K.W. Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem 401, 1915–1922 (2011). https://doi.org/10.1007/s00216-011-5251-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5251-5